RPL21 and head and neck squamous cell carcinoma: For instance, HNSCC patients with low expression of the RPL21-201 isoform showed an almost 3.5 years longer medium survival than HNSCC patients with high expression of this 5′UTR isoform (89 vs. 48 months).